Genentech’s Post

🧬 Transform Cancer Care with Myriad Genetics' Comprehensive Oncology Portfolio 🧬 Did you know? Patients with a cancer diagnosis can benefit from germline testing. According to the American Society of Clinical Oncology (ASCO)'s latest guidelines, up to ~8-10% of germline pathogenic variants (PVs) are missed when relying solely on tumor testing. This underscores the critical need to pair MyRisk® germline testing, MyChoice® CDx for HRD testing, and Precise® Tumor genomic profiling, to ensure no vital information is overlooked. #precisionmedicine #oncology #cancercare #ovariancancerawarenessmonth https://lnkd.in/gHcfzBf3

🌟 September is Prostate Cancer Awareness Month! 🌟 📌 Did you know that prostate cancer is the #1 most diagnosed cancer among Canadian men, accounting for 1 in 5 new cancer cases? Almost all prostate cancer is treatable and, in many cases, it can be eliminated – particularly when it is diagnosed early. (https://lnkd.in/dEJSBE7A - Prostate Cancer Foundation Canada) 💙This month, we encourage all men to prioritize their health by staying up to date with checkups. Early diagnosis provides the best chance for a positive outcome. Here's what Dr. Steve Yip, GU Medical Oncologist has to say about prostate cancer and how genetic testing can help clinicians select the optimal treatment pathway. Alberta Cancer Foundation #ProstateCancerAwareness #MensHealth #EarlyDetection #OncoHelix #HealthcareAwareness #BetterInsights #BetterHealth

Collectively, rare cancers account for 22% of all cancer diagnoses; however, individually, each type affects only a small number of people. Because of their rarity, these cancer types pose a significant challenge for research, diagnosis, and treatment. This visual explainer provides insights into the impact of rare cancers among Australians and how this impact differs depending on where people live. https://lnkd.in/geQxBfnd

May not be a simple fact but one of my publications on prostate cancer (Zanchetta, M. S., Cognet, M., Lam-Kin-Teng, M.-R., Rhéaume, J., Renaud, L., & Dumitriu, M.-E. (2016). Reading beyond the blog testimonies of survivors’ quality of life and prostate cancer representation. Health and Quality of Life Outcomes, 14, 171. doi: 10.1186/s12955-016-0568-6) as one of the outcomes of my sabbatical research at the Universite Paris Diderot (supported by Union International for Cancer Control-UICC) was cited in the article at The Lancet: The Lancet Commission on prostate cancer: planning for the surge in cases April 2024The Lancet DOI: 10.1016/S0140-6736(24)00651-2

🔍 Information & Facts about Breast Cancer: 📊 Fact 1: The survival rate for early-stage breast cancer is over 90% with proper treatment. 👩⚕️ Fact 2: Breast cancer can also occur in younger women, not just those over 50. 💪 Fact 3: Maintaining a healthy weight, limiting alcohol, and staying physically active can reduce the risk of breast cancer. ⚠️ Fact 4: Triple-negative breast cancer is more aggressive and more common in younger women and those of African or Asian descent. 🧬 Fact 5: Genetic testing can help identify mutations like BRCA1 and BRCA2, which increase the risk of breast cancer. Dr. Veenoo Agarwal Consultant - Medical Oncologist 📞 +91 96677 69023 🌐 www.drveenoo.com #BreastCancerAwareness #CancerFacts #EarlyDetection #OncologyCare #DrVeenooAgarwal

🎖️Check out the Editor's Choice #Review "Is Immunotherapy Beneficial in Patients with Oncogene-Addicted Non-Small Cell Lung Cancers? A Narrative Review" 👨🔬by David John McMahon et al. St James's Hospital Dublin 📌Link here: https://lnkd.in/dArBh_Qv 🔹Oncogene-addiction is defined as a process which drives cancer development and survival with one or several genetic, epigenetic, or chromosomal aberrations. This review summarized the efficacy and safety of immune check inhibitors in the treatment of non-small cell lung cancer patients, based on the oncogene-addiction🔹

Did you know? presented by The Cancer Screening, Detection, and Risk Reduction Research Program (CanDoR) September marks Prostate Cancer Awareness Month. Did you know 74% of prostate cancers are diagnosed early, in either stage I or II? This is all thanks to the great advancements in screening and cancer detection. Earlier-stage cancers respond better to treatment and result in more survivors. Look for signs and symptoms and talk to your health care provider early!

Prostate cancer is one of the most common cancers diagnosed in Canadian men. As September marks Prostate Cancer Awareness Month, it's a crucial time to learn about prostate health and the factors that increase the risk of prostate cancer. 💙 The decision to screen for prostate cancer is a personal one and should be made after discussing the potential benefits and risks with your doctor and whether screening is right for you.. Screening, such as the Prostate-Specific Antigen (PSA) test, can detect prostate cancer early but may also lead to unnecessary treatments. Learn more about prostate health, the risks, and considerations around prostate cancer screening: https://bit.ly/45Ru6Lg #ProstateCancerAwarenessMonth #KnowYourRisk

Cancer Invest Cancer Invest. 2007 Jun;25(4):226-31. doi: 10.1080/07357900701206323. Beclin 1 mRNA strongly correlates with Bcl-XLmRNA expression in human hepatocellular carcinoma F Daniel 1, A Legrand, D Pessayre, F Borrega-Pires, L Mbida, B Lardeux, C Degott, J Tran van Nhieu, D Bernuau PMID: 17612932 DOI: 10.1080/07357900701206323

Prostate cancer is one of the most common cancers diagnosed in Canadian men. As September marks Prostate Cancer Awareness Month, it's a crucial time to learn about prostate health and the factors that increase the risk of prostate cancer. 💙 The decision to screen for prostate cancer is a personal one and should be made after discussing the potential benefits and risks with your doctor and whether screening is right for you. Screening, such as the Prostate-Specific Antigen (PSA) test, can detect prostate cancer early, but could also lead to unnecessary treatments. Learn more about prostate health, the risks, and considerations around prostate cancer screening: https://bit.ly/45Ru6Lg #ProstateCancerAwarenessMonth #KnowYourRisk